Alexandria Forbes, MeiraGTx CEO (Hollie Adams/Bloomberg via Getty Images)
Gene therapy biotech uses its manufacturing sites as collateral to net a $100M loan
Gene therapy biotech MeiraGTx is looking to get some quick cash and is putting up its manufacturing facilities to do it.
On Wednesday the company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
